Viatris has delayed the big reveal of details of its two-phase strategic roadmap that had been due to take place at an investor event planned for early January.
Investors and industry analysts will now have to wait a little longer to learn details of Viatris’ long-term “strategic roadmap,” after the company announced that an investor event scheduled for 7 January 2022 had been delayed to “no later than 28 February when the company expects to report its fourth quarter 2021 results.”
Viatris had in November unveiled plans for the “virtual investor event” in January, which it said would include detailed financial...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
